1. Home
  2. WLK vs NBIX Comparison

WLK vs NBIX Comparison

Compare WLK & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westlake Corporation

WLK

Westlake Corporation

HOLD

Current Price

$93.57

Market Cap

14.7B

Sector

Industrials

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$160.10

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLK
NBIX
Founded
1986
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7B
13.2B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
WLK
NBIX
Price
$93.57
$160.10
Analyst Decision
Buy
Strong Buy
Analyst Count
15
22
Target Price
$106.87
$180.91
AVG Volume (30 Days)
1.0M
1.2M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.90%
N/A
EPS Growth
N/A
41.95
EPS
N/A
1.91
Revenue
$11,170,000,000.00
$161,626,000.00
Revenue This Year
$5.51
$24.73
Revenue Next Year
$3.74
$13.14
P/E Ratio
N/A
$84.44
Revenue Growth
N/A
977.51
52 Week Low
$56.33
$117.84
52 Week High
$124.23
$161.77

Technical Indicators

Market Signals
Indicator
WLK
NBIX
Relative Strength Index (RSI) 31.65 79.51
Support Level $91.76 $125.54
Resistance Level $103.00 N/A
Average True Range (ATR) 3.85 4.41
MACD -2.00 2.94
Stochastic Oscillator 4.53 94.60

Price Performance

Historical Comparison
WLK
NBIX

About WLK Westlake Corporation

Westlake Corp is a vertically integrated international manufacturer and marketer of both housing and infrastructure products and performance and essential materials that are designed to enhance the lives of people every day. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and international compounds businesses.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: